lilly's glp 1 FDA approves new weight-loss pill, Foundayo Lilly's GLP-1 pill outperforms Novo's

If a maintenance dose lower than the maximum dose is being used, the new GLP1RA should be initiated at the lowest available dose

Cost Comparison: Anthem Coverage Versus PlexusDx Direct Access If Anthem denies coverage or requires a copay exceeding $250 monthly, PlexusDx compounded semaglutide at $149 per month becomes financially attractive

The FDA removed tirzepatide from the drug shortage list in December 2024 and semaglutide in February 2025, eliminating the primary legal basis for "essentially a copy" compounding of these substances

This creates an important distinction: Absence of long-term micronutrient data does not equal evidence of depletion but neither does it confirm absence of risk

Individuals with obesity, compared to those with a healthy weight, have increased risk for several serious diseases and conditions, including hypertension, asthma, heart disease, stroke, type 2 diabetes, many cancers, breathing difficulty, and joint issues

Watch this quick tutorial video which takes you around the website